Dr. Alexander Sardiña is the CEO of Whiterabbit. With two decades of experience in the healthcare industry and a deep expertise in both mammography and cross-sectional imaging, Dr. Sardiña focuses on accelerating Whiterabbit’s growth in new markets and expanding its product offerings.

‍

Before Whiterabbit, Dr. Sardiña served as the chief medical officer (CMO) for Solis Mammography, one of the largest mammography providers in the country. He also served as the CEO and Chief Medical Officer of Covia Health, a Houston-based 3D mobile mammography provider.

‍

Dr. Sardiña conducted most of his training in Houston at the Texas Medical Center while attending Baylor College of Medicine. and The University of Texas Health Science Center/ MD Anderson Cancer Center. He also obtained a radiology fellowship from The Johns Hopkins Hospital.

‍

Jason is an engineer and scientist who has always sought to make an impact on the world through invention. His early childhood fascination with technology grew into an interest for building things to help people. This passion led him to pursue his doctoral work at Stanford University in medical imaging and computer vision. He worked on the cutting-edge of imaging and treatment techniques to deliver better health outcomes for patients with essential tremor and was an early innovator in applying deep learning to the diagnosis of diabetic retinopathy.

‍

This journey led Jason to found Whiterabbit to examine and create innovations at the intersection of medical imaging and AI to push the limits of early disease detection.

‍

Jason has authored multiple peer-reviewed publications and conducted research across a range of neurological diseases. Jason received his Bachelor of Science in Electrical Engineering and Applied Physics from Rensselaer Polytechnic Institute, he received his Master's Degree and is a doctoral candidate in Electrical Engineering at Stanford University.

‍

Before Whiterabbit.ai, Jerry served as Chief Financial Officer for Sight Machine, a Series C manufacturing analytics software company, and held senior finance roles at Mighty Buildings and Grabango.

‍

Prior to his operational finance career with technology startups, he was an institutional investor with Premji Invest and Grand River Investments and an investment banker in the technology sector with Merrill Lynch and Credit Suisse First Boston.  Having started his career in Silicon Valley as an engineer, Jerry’s experience has been at the intersection of technology and finance with a focus on enabling and guiding emerging technology companies to achieve growth.

‍

Jerry holds BS and MS electrical engineering degrees from Stanford University and an MBA from The Wharton School, University of Pennsylvania.  He is a CFA charterholder.

A career spent at the forefront of cloud, mobile, and communication technologies, Jon has a 15 year operational record of investing, founding, and building high growth technology companies.  

‍

First a seed investor and now Chief Business Officer of Whiterabbit, Jon's personal experience navigating breast cancer led him to join the mission of eliminating suffering through early detection.  

‍

Prior to Whiterabbit, Jon has been a member of the founding teams of several high growth technology businesses including Highfive and Vivu, acquired by Polycom. Jon is also a venture partner of the Craftory, a $300m investment house for challenger brands. He is a graduate of Boston College.

Marguerite is a regulatory and quality leader with over 20 years of medical device expertise. She has led hundreds of FDA and international regulatory submissions for instrument and software devices (SaMD) including wearable technology, hospital connectivity, critical-care patient monitoring, and IVD diagnostics.

Prior to Whiterabbit, Marguerite was Senior Director of Regulatory Affairs for Masimo Corporation, specializing in hospital automation and noninvasive medical innovation. Before that she was Director of Regulatory Affairs for Edwards Lifesciences, focusing on cardiovascular technology. She also worked in product development and engineering management at B. Braun Medical, CareFusion, Teledyne, and Boeing. 

Marguerite holds a Bachelor of Science in Mechanical Engineering from California State Polytechnic University and a Juris Doctorate from Western State College of Law.

Dr. Alexander Sardiña is the CEO of Whiterabbit. With two decades of experience in the healthcare industry and a deep expertise in both mammography and cross-sectional imaging, Dr. Sardiña focuses on accelerating Whiterabbit’s growth in new markets and expanding its product offerings.

‍

Before Whiterabbit, Dr. Sardiña served as the chief medical officer (CMO) for Solis Mammography, one of the largest mammography providers in the country. He also served as the CEO and Chief Medical Officer of Covia Health, a Houston-based 3D mobile mammography provider.

‍

Dr. Sardiña conducted most of his training in Houston at the Texas Medical Center while attending Baylor College of Medicine. and The University of Texas Health Science Center/ MD Anderson Cancer Center. He also obtained a radiology fellowship from The Johns Hopkins Hospital.

Jason is an engineer and scientist who has always sought to make an impact on the world through invention. His early childhood fascination with technology grew into an interest for building things to help people. This passion led him to pursue his doctoral work at Stanford University in medical imaging and computer vision. He worked on the cutting-edge of imaging and treatment techniques to deliver better health outcomes for patients with essential tremor and was an early innovator in applying deep learning to the diagnosis of diabetic retinopathy.

‍

This journey led Jason to found Whiterabbit to examine and create innovations at the intersection of medical imaging and AI to push the limits of early disease detection.

‍

Jason has authored multiple peer-reviewed publications and conducted research across a range of neurological diseases. Jason received his Bachelor of Science in Electrical Engineering and Applied Physics from Rensselaer Polytechnic Institute, he received his Master's Degree and is a doctoral candidate in Electrical Engineering at Stanford University

Neel Patel is CEO and Founder of OM Pacific Capital, a Multi-Family Office based in the Bay area. He started the firm in 2015. His firm manages capital for multiple families and Institutional clients across all asset classes including Equities, Fixed Income, Hedge Funds, Private Equity, Real Estate, Venture Capital and Private Credit.  

‍

Neel started to invest directly in venture backed companies starting in 2015 through the Venture Capital arm of his firm, Aceso Technology Partners. They invest at seed and Series A, and opportunistically in Series B. Sectors include: Technology, i.e. SaaS companies, Artificial Intelligence, Healthcare/Health-Tech, Bio-Tech, Real Estate Tech, Climate-Tech and Fin-Tech. Several of their portfolio companies have gone IPO or been acquired through M&A.  

‍

Neel spent 10 years at Merrill Lynch in their ultra-high-net-worth group and Institutional division. Prior to that, he was a Bond trader for PIMCO in Newport Beach. Neel graduated from University of the Pacific with a B.S. in Finance.

Jessica Beegle is a leading enterprise growth executive working at the intersection of healthcare and technology. With a focus on transforming businesses through innovation, she excels in creating new business models, pioneering de novo business ventures, and integrating advanced technologies such as cloud computing and artificial intelligence, in regulated sectors, from consumer health to clinical care and drug development. She brings the unique ability to bridge traditional healthcare enterprises with emerging technology companies to drive real-world adoption of cutting-edge solutions with the goal of providing better health outcomes for all.

‍

As the inaugural Senior Vice President & Chief Innovation Officer at Lifepoint Health, a diversified healthcare system under Apollo Global Management, Jessica led digital transformation initiatives that spanned 62 hospitals, 62 rehab and behavioral centers, and 250 additional care sites across 31 states. She partnered with Google and Palantir to create the company's first integrated enterprise data lake, significantly improving operational efficiencies and patient outcomes, spearheaded the system's introduction of generative AI solutions to reduce clinical administrative work, and championed the enterprise roll-out of remote patient monitoring programs to enhance patient access to care, while reducing total cost of care. Additionally, she spearheaded a $30 million strategic investment joint venture between Apollo, Lifepoint, and 25Madison, investing in leading companies like Abridge, Midi Health, Cadence, and BioIntelliSense and building de novo startups.

‍

Before Lifepoint, Jessica was integral to the founding team that incubated and launched Walgreens Health, expanding Walgreens Boots Alliance's role in healthcare by delivering new high-value solutions to payers, health systems, PBMs, and pharmaceutical manufacturers. At Google, she led consumer efforts for Google Health, helping connect and bring meaning to consumers' digital health journeys across major Google products such as Search, Maps, YouTube, Android, and Nest, and drove global market development and expansion for Google's Artificial Intelligence unit, DeepMind, as it began commercializing AI solutions in healthcare. At Amazon Web Services (AWS), she created the Healthcare & Life Sciences vertical business and successfully established AWS as the premier public cloud partner for healthcare and life sciences organizations across the globe, helping reinvent the way organizations collaborate, make data-driven clinical/operational decisions, and accelerate innovation from bench top to bedside.

‍

Her career began at General Electric, where she contributed to the $6 billion healthymagination strategy, leveraging GE's diverse capabilities to tackle global healthcare challenges. Jessica's influence extends to her roles with the World Economic Forum, serving on the Global Agenda Council for Brain Research, Meta-Council on the Future of Health, Future of the Internet Working Group, and Global Shapers. She has advised and held board positions with numerous innovative startups, including Abridge, Cadence, OMNY Health, Science37, Arterys, and A.Team. She also serves on the Board of the United Way of Nashville Toqueville Society and is a sought-after keynote speaker and panelist at leading financial, tech, and innovation conferences hosted by JP Morgan, Morgan Stanley, HLTH, ViVE, and the Nashville Healthcare Council.

‍

Jessica has been named to the Becker's Healthcare Top Chief Innovation Officer, Top Chief Transformation Officer, and the Nashville Business Journal Women of Influence- Top Executive lists, further recognizing her impact on the industry. She holds a J.D. from Southern Methodist University Dedman School of Law and a B.A. from the University of Georgia. Jessica is also a graduate of GE’s Executive Commercial Leadership Program (ECLP) and the Executive Education Program at Harvard Business School.

‍

‍